Acrivon Therapeutics (ACRV) Depreciation and Depletion (2021 - 2026)
Acrivon Therapeutics (ACRV) reported Depreciation and Depletion of $400,000 for Q2 2026, up 33.3% from $300,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Depreciation and Depletion (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Acrivon Therapeutics' Depreciation and Depletion came in at $1.5 million, up 23.6% year-over-year; for FY2025, it came in at $1.4 million, up 39.2% from FY2024.
- Depreciation and Depletion has increased for four consecutive years, with a four-year compound annual growth rate of 148.0% (FY2021 to FY2025).
- By year, Depreciation and Depletion came in at $1.01 million in FY2024 (+87.7%), $536,000 in FY2023 (+34.0%), $400,000 in FY2022 (+981.1%) and $37,000 in FY2021.
- Year over year, Depreciation and Depletion has now increased in each of the last three quarters, with growth averaging 63.2% over the last eight quarters.
- The high point for year-over-year Depreciation and Depletion in five years was Q3 2024 (growth of 200.0%); the low point was Q4 2023 (a decline of 15.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $400,000 (Q1 2026), $400,000 (Q4 2025) and $300,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Acrivon Therapeutics | 85.27 Mn | 85.27 Mn | - | 400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 311,000.00 |
| Dec 31, 2024 | 303,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 136,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 125,000.00 |
| Dec 31, 2022 | 161,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 9,000.00 |
API Access
Acrivon Therapeutics Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();